Signals+ October 2022

Photo of the 2024 award winners in Seoul, Korea

Recognizing Excellence: ICIS Celebrates the 2024 Award Winners

by Stephanie Flores in Awards

Last month nearly 2,000 leading cytokine, interferon and immunology investigators from 36 countries came together in Seoul to network, share knowledge and make new friends. Please enjoy these photos and highlight video.

Photo Albums & Survey: Thank you to everyone who was able to join us at Cytokines 2024 & KAI 2024

November 19, 2024

Last month nearly 2,000 leading cytokine, interferon and immunology investigators from 36 countries came together in Seoul to network, share knowledge and make new friends.

Please enjoy these photos and highlight video.

We might be biased, but we think this year’s conference will go down in ICIS history as particularly special. To help us improve future meetings, we would greatly appreciate it if you could take a few moments to complete our online survey by this Friday, November 22, 2024. [READ MORE]

International Cytokine & Interferon Society (ICIS) favorite feeds and people - join us!

Join the conversation with your favorite feeds & people on Bluesky

November 19, 2024

We’re in the process of moving here from X. Join us, follow & share your research & publications (cytokine related or outside the boundaries, published or pre-pub), job openings, meetings & informal gatherings where great ideas are born & cultivated
@cytokinesociety.bsky.social [READ MORE]

Member Highlight Interview: Rosa Nguyen

November 18, 2024

My lab focuses on the development of novel immunotherapies for pediatric solid tumors. We take the most promising discoveries and translate them into the clinic. [READ MORE]

Recognizing Excellence: ICIS Celebrates the 2024 Award Winners

November 18, 2024

The International Cytokine & Interferon Society (ICIS) is proud to honor outstanding contributions to the field of cytokine and interferon research through its comprehensive awards program. Designed to recognize excellence at every stage of a scientist’s career, the ICIS awards underscore the Society’s commitment to fostering innovation, mentorship, and impactful [READ MORE]

Image of stacked magazines with title, "Article of Interest"

Don’t Eat Me: Overcoming a Tumor’s Immunosuppressive Microenvironment

November 18, 2024

Targeting EGFRvIII and CD47-SIRPα: A New CAR-T Strategy for Glioblastoma Treatment Review contributed by: PhD candidate Eugenio Contreras Castillo (one of the 2024 ICIS-Pfizer Trainee Award Winners for Most Promising Research Presentations at Cytokines 2024), Department of Cell Biology Institute of Cellular Physiology (IFC), National Autonomous University of Mexico (UNAM) [READ MORE]

Clinical Trials, contributed by Howard A. Young

Clinical Trials – updated November 20, 2024

November 18, 2024

1) Effects of Interleukin (IL)-17A Inhibition on Idiopathic Subglottic Stenosis (ClinicalTrials.gov ID NCT05309616) | 2) Assessment of Serum interleukin10 Level in Patients With Immune Thrombocytopenic Purpura at Sohag University Hospital (ClinicalTrials.gov ID NCT05835050) | 3)Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma (DiTuSarc) (ClinicalTrials.gov ID NCT05080790) [READ MORE]

Biweekly newsletter of the International Cytokine & Interferon Society

Signals+ Editors: Daniella Schwartz & Di Yu (Editors in Chief), Saurabh Chattopadhyay, Zhian Chen, Mohamed Saad & Maialen Sebastian-delaCruz

Recognizing Excellence: ICIS Celebrates the 2024 Award Winners

Cytokines / KAI 2024 Sponsors

Share this:

Cytokines / KAI 2024 Sponsors